首页> 外国专利> PROCESS FOR PREPARATION OF PURIFIED NUCLEIC-ACID SEQUENCE CORRESPONDING TO HUMAN GP39, OF CORRESPONDING SOLUBLE GP39, AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, AND PROMOTING OF B-CELL PROLIFERATION

PROCESS FOR PREPARATION OF PURIFIED NUCLEIC-ACID SEQUENCE CORRESPONDING TO HUMAN GP39, OF CORRESPONDING SOLUBLE GP39, AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, AND PROMOTING OF B-CELL PROLIFERATION

机译:对应于人GP39,对应的可溶性GP39的纯化核酸序列的制备及其所含药物成分的制备,以及促进B细胞增殖的方法

摘要

The present invention relates to a process for the preparation of a purified gp39-corresponding purified nucleic acid sequence in a manner that would form L234F, L235E and G237A mutations in the CD40-Igimmoglobulin genome. supplemented by a chain reaction, positive clones are selected by hybridization with primers containing primers containing the above-mentioned sequences corresponding to the above-mentioned sequence, and the desired female cleavage sequence is selected by immunoprecipitation from apositive clones. The present invention relates to the preparation of a killed gp39 protein of the corresponding amino acid sequence and to pharmaceutical compositions containing it, and to the in vitro amplification of B cell proliferation using the killed gp39 protein produced. ŕ
机译:本发明涉及一种以在CD40-免疫球蛋白基因组中形成L234F,L235E和G237A突变的方式制备与gp39相对应的纯化核酸序列的方法。通过链反应的补充,通过与包含含有与上述序列相对应的上述序列的引物的引物杂交来选择阳性克隆,并且通过免疫沉淀从阳性克隆中选择期望的雌性切割序列。本发明涉及具有相应氨基酸序列的被杀死的gp39蛋白的制备和包含它的药物组合物,并涉及使用产生的被杀死的gp39蛋白的B细胞增殖的体外扩增。 ŕ

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号